Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Veltkamp

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|October 6, 1973
Letter: Factor VIIIJ J Veltkamp
Nederlands Tijdschrift Voor Geneeskunde|December 8, 1979
[Current status of hemophilia treatment]J J Veltkamp
Nederlands Tijdschrift Voor Geneeskunde|January 4, 1975
[Genetic aspects of hemophilia A and B]J J Veltkamp
Mayo Clinic Proceedings|December 1, 1974
Detection and clinical significance of PIVKAJ J Veltkamp
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1973
The diagnostic value of coagulation studies in chronic liver diseaseJ J Veltkamp, J Kreuning
British Journal of Haematology|August 1, 1979
A genetic variant of factor IX with decreased capacity for Ca2+ bindingR M Bertina, J J Veltkamp
Thrombosis and Haemostasis|October 31, 1978
The abnormal factor IX of hemophilia B+ variantsR M Bertina, J J Veltkamp
Northwest Medicine|June 1, 1970
Drug therapy. V. Oral anticoagulant therapyJ S Holcenberg, J J Veltkamp
Experientia|August 15, 1974
Control of anticoagulation in ratsA T Van Oosterom, J J Veltkamp
British Journal of Haematology|January 1, 1974
'Autosomal haemophilia': a variant of von Willebrand's diseaseJ J Veltkamp, N H van Tilburg
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|October 6, 1973
Letter: Factor VIIIJ J Veltkamp
Nederlands Tijdschrift Voor Geneeskunde|December 8, 1979
[Current status of hemophilia treatment]J J Veltkamp
Nederlands Tijdschrift Voor Geneeskunde|January 4, 1975
[Genetic aspects of hemophilia A and B]J J Veltkamp
Mayo Clinic Proceedings|December 1, 1974
Detection and clinical significance of PIVKAJ J Veltkamp
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1973
The diagnostic value of coagulation studies in chronic liver diseaseJ J Veltkamp, J Kreuning
British Journal of Haematology|August 1, 1979
A genetic variant of factor IX with decreased capacity for Ca2+ bindingR M Bertina, J J Veltkamp
Thrombosis and Haemostasis|October 31, 1978
The abnormal factor IX of hemophilia B+ variantsR M Bertina, J J Veltkamp
Northwest Medicine|June 1, 1970
Drug therapy. V. Oral anticoagulant therapyJ S Holcenberg, J J Veltkamp
Experientia|August 15, 1974
Control of anticoagulation in ratsA T Van Oosterom, J J Veltkamp
British Journal of Haematology|January 1, 1974
'Autosomal haemophilia': a variant of von Willebrand's diseaseJ J Veltkamp, N H van Tilburg
Pageof 7